Nature Medicine, Published online: 26 August 2026; doi:10.1038/s41591-026-04606-0
A natural experiment comparing recipients of the live attenuated versus recombinant herpes zoster vaccines found that the recombinant vaccine was associated with a lower incidence of cardiovascular events across 7 years of follow-up.
